Mercados españoles abiertos en 5 hrs 25 min

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
113,99+2,23 (+2,00%)
Al cierre: 04:00PM EST
116,27 +2,28 (+2,00%)
Después del cierre: 07:34PM EST

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500

SectorDiagnostics & Research
Empleados a tiempo completo11.500

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Dr. Joydeep Goswami M.B.A., Ph.D.CFO, Chief Strategy & Corporate Development Officer787,3kN/A1971
Ms. Susan H. TousiChief Commercial Officer790,2kN/A1969
Mr. Jacob Thaysen Ph.D.CEO & DirectorN/AN/A1975
Stephanie CamposPresidentN/AN/AN/A
Mr. Kevin Carl PegelsChief of Global OperationsN/AN/A1967
Mr. Scott EricksenVP & Chief Accounting OfficerN/AN/A1972
Dr. Steven Barnard Ph.D.Chief Technology OfficerN/AN/AN/A
Ms. Carissa L. RollinsChief Information OfficerN/AN/A1970
Ms. Sallilyn SchwartzVice President of Investor RelationsN/AN/AN/A
Mr. Charles E. Dadswell Esq.Senior VP & General Counsel1,06MN/A1959
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.


Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Gobierno corporativo

El ISS Governance QualityScore de Illumina, Inc., a día 1 de diciembre de 2023, es 10. Las puntuaciones base son Auditoría: 9; Tablero: 8; Derechos de los accionistas: 6; Compensación: 10.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.